000			02323nam a2200553 i 4500
001			ocn681930261
003			OCoLC
005			20190831111939.0
006			m o d f
007			cr bn||||||ada
008			101117s1993 mdua ob f000 0 eng c
010			_z93231211
019			_a1084864490
040			_aOCLCE _beng _erda _epn _cOCLCE _dOCLCQ _dOCLCF _dOCLCO _dOCLCQ _dOCLCO _dOCL _dOCLCO _dOCLCQ _dOCLCO _dOCLCQ _dGILDS _dOCLCO _dOCLCA _dINARC _dGPO _dMvI
042			_adlr _apcc
043			_an-us---
074			_a0831-C-12 (online)
086	0		_aHE 20.3965:133 _zHE 20.8216:133
099			_aHE 20.3965:133
245	0	0	_aSigma, PCP, and NMDA receptors / _ceditors: Errol B. De Souza, Doris Clouet, Edythe D. London.
246	3		_aSigma, phencyclidine, and N-methyl D-aspartate receptors
264		1	_aRockville, MD : _bU.S. Department of Health and Human Services, Public Health Service, Substance Abuse and Mental Health Services Administration, National Institute on Drug Abuse, _c1993.
300			_a1 online resource (iv, 244 pages) : _billustrations.
336			_btxt
337			_bc _2rdamedia
338			_bcr _2rdacarrier
490	1		_aNIH publication ; _vno. 93-3587
490	1		_aResearch monograph ; _v133
504			_aIncludes bibliographical references.
500			_aCRDP Program record.
588			_aDescription based on online resource, PDF version; title from title page (NIDA, viewed April 3, 2019).
650		0	_aPhencyclidine _xReceptors.
650		0	_aMethyl aspartate _xReceptors.
650		0	_aSigma receptors.
650		0	_aNeural receptors.
650		0	_aDrug abuse _zUnited States.
650		7	_aMethyl aspartate. _2fast _0(OCoLC)fst01018741
650		7	_aNeural receptors. _2fast _0(OCoLC)fst01036274
650		7	_aPhencyclidine. _2fast _0(OCoLC)fst01060476
700	1		_aDe Souza, Errol B., _eeditor.
700	1		_aClouet, Doris H., _eeditor.
700	1		_aLondon, Edythe D., _eeditor.
710	2		_aNational Institute on Drug Abuse, _eissuing body.
776	0	8	_iPrint version: _tSigma, PCP, and NMDA receptors _w(DLC) 93231211 _w(OCoLC)28766866
830		0	_aNIH publication ; _vno. 93-3587.
830		0	_aNIDA research monograph ; _v133.
856	4	0	_uhttps://purl.fdlp.gov/GPO/gpo118894
949			_aBEV _bFed Docs
999			_c285678 _d285678